Advertisement
Advertisement
U.S. markets open in 39 minutes
Advertisement
Advertisement
Advertisement
Advertisement

RegeneRx Biopharmaceuticals, Inc. (RGRX)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1792-0.0028 (-1.54%)
At close: 3:51PM EDT
Advertisement
Sign in to post a message.
  • t
    t8km9
    JJ is definitely making maneuvers now. Between the new shares "authorized" last week and the press releases of two weeks ago. The difference now is these maneuvers are meant for public consumption.

    I have no inside information at all. I will hazard a guess that these are designed to give the company flexibility and discretion time, the freedom to decide what should be done in a particular situation.

    This does not smell like desperation to me. It looks like they are choreographing a sequence of steps to begin to position the company in as strong a light as possible for M&A activity.
  • D
    DrW
    Of all the discussion today, no one has addressed this by JJ as 1 of 2 reasons for the 100M authorization request: "We are also exploring the future possibility of seeking to have our Common Stock traded on Nasdaq or another national exchange. Without increasing our authorized, but unissued, shares of Common Stock, we may find it difficult, if not impossible, to raise additional capital if required to finance our operations, and we would also be unable to consider an uplisting of our Common Stock to a national exchange". It makes no sense to me to be thinking about an uplisting at present time yet JJ makes it a reason for his requested share increase. Why? and what would it require? I'm guessing we all know.
    Imo, I don't see the requested share increase as providing a survival net if BLA is a failure. Those shares upon a BLA failure will not bring in sufficient funds for new trials or continued operations, imo. I think JJ knows what he has, that he is confident that DES approval will be obtained, and this share request is part of his game plan for the eventual "wealth distribution." I have no doubt there will be shares issued with corresponding dilution, and there will be more granting of shares/options/warrants again to mgt/insiders at the expense of long term shareholders. Where I could be wrong is if a pre-BLA BO should occur. But why even mention the uplisting if you are not serious about it? It only opens the door to a plethora of potential difficulties as anyone who has been part of that experience knows all too well. Let's hope for a good BLA meeting and a pharma who wants to clean house with all of TB4's potential so JJ & Board can retire and long term holders get a reasonable return for their patience. GLTA
  • D
    DrPiano5
    From Gtree website- imagine if only JJ put something as cheesy as this

    “ We would like to apologize once again to shareholders who must have had a difficult time due to the large share price drop. I promise to do my best to make it happen.
    We would like to thank our shareholders once again, and we will do our best to repay you with good results by successfully completing the extraordinary general meeting of shareholders scheduled for the 29th and attracting investment.
  • d
    dontu1dr
    Rgrx/Regentree seemingly has the goods,,,
    to pass the FDA's updated guidance...

    MIGHT want to REVIEW the 2 REGENTREE,,,
    PATENT APP'S (the 2019 application is now a patent)...

    https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=regentree&FIELD1=&co1=AND&TERM2=&FIELD2=&d=PG01

    NEWEST PATENT APP:
    Appl. No.: 17/185583

    CLAIMS:
    1. A method of improving tear film stability in a subject in need thereof, comprising: administering an ophthalmic composition containing from about 0.05% to about 0.1% by weight of an active agent, wherein the active agent is selected from the group consisting of T.beta.4, a peptide comprising amino acid sequence LKKTET [SEQ ID NO:1], and a peptide comprising amino acid sequence LKKTNT [SEQ ID NO:2], wherein the subject has a tear film break up time of less than 10 seconds, wherein the subject has a lower tear film stability as compared to the subject having higher tear film stability, wherein the tear film stability is associated with dry eye syndrome, and wherein the subject has a mean change in a tear film break up time that is more than twice that of the subject having higher tear film stability.

    10. A method of improving ocular discomfort in a subject in need thereof, comprising: administering an ophthalmic composition containing from about 0.05% to about 0.1% by weight of an active agent, wherein the active agent is selected from the group consisting of T.beta.4, a peptide comprising amino acid sequence LKKTET [SEQ ID NO:1], and a peptide comprising amino acid sequence LKKTNT [SEQ ID NO:2], wherein the subject has an ocular discomfort score of about 2 or higher, wherein the subject has a higher symptomatic score as compared to a subject having a lower symptomatic score that has an ocular discomfort score less than 2, and wherein the ocular discomfort is associated with dry eye syndrome.

    SO,,, YOU CAN see what they're "shooting for",,,
    and are GETTING PATENT COVERAGE ON...

    If you like to go a little deeper in DD,,,
    open the 2019 application (now a patent):
    Appl. No.: 16/318571

    ENTER THE ABOVE # AND GO INTO USPTO PUBLIC PAIR...

    THEN OPEN TAB:
    IMAGE FILE WRAPPER

    SCROLL DOWN TO:
    11-06-2020 Applicant Arguments/Remarks Made in an Amendment

    click on it and download the pdf
    Spend some time in it---no kidding

    It really get's into the interesting stuff,,,
    3rd page of the pdf
    OR
    page 7 on the bottom of the documents

    MAYBE PRINT OUT AND DO some UNDERLINING,,,
    as it's kinda choppy as they discussed it...lol

    Second paragraph discusses:
    treating non dry eye syndrome factors

    WHAT THEY REALLY MEAN IS:
    iatrogenic dry eye
    DEFINITION
    iatrogenic
    adjective
    relating to illness caused by medical examination or treatment.

    THEY then give examples:
    refractive laser surgery
    AND
    drug toxicity

    So they had subsets of folks with:
    iatrogenic dry eye= laser surgery and drug toxicity

    WHICH is a HUGE UNMET NEED,,,
    and HARD TO HEAL as the CORNEA is DAMAGED...

    THEN,,, in the same paragraph,,,
    they say that "the corneal staining" decreases
    after "administering disclosed subject matter"

    That's CRITICAL to BIG EYE PHARMA,,,
    and you have to understand what they're up against...
    I'll post a very recent article,,,
    in a separate column,,,
    so you can see what REAL PROBLEMS,,,
    surgery and lasik,,,
    are up against...
    HUGE UNMET NEED
    and
    tb4 EYE is seemingly a "can do",,,
    for the job...

    THE DONKER
    Bullish
  • s
    sno
    IMO, JJ knows what he is doing on this. The 100 mill shares is boilerplate....he knows where RGRX goes on bad BLA news. he knows it goes up a decent amount on good BLA news. Far easier to raise a few million with a HIGHER stock price. Also? If you look back at the last PIPE, if he is careful on spending, it tides him over till early Fall 2022. Catch the timing? IF, IF the BLAgoes well and they agree a final approval review, the standard time is 10 months...which, if BLA news is soon....JJ has it so he is basicallly funded till that time. It is possible, if the data impresses....that they give an expedited 6 month review.....but from what I see, JJ did the PIPE to carry him to the 10 month situation.. JJ is not issuing any news shares anytime soon....unless RGRX pops higher that we think if BLA accepted....JJ might riase a few million just to be safe. Never forget JJ is 69....70 next year. ALL of RGRX mgmt and BOd are OLD OLD OLD....McNay late 80's....dr. Goldstein about 84. Thety look forward to monitizing what they have and retiring very nicely. FOCUS ON BLA NEWS, drop this endless posting on the 100 mill shares maybe authorized but NOT ISSUED>!
  • D
    DrW
    IMO, red flags waving. If JJ really wants back on Nasdaq, can't see that happening without a big RS. The request for 100M instead of a lesser amount also indicates a RS possibility. It is very typical behavior of biotech, authorize a very large amount of shares pre-RS so a reasonable amount remain after RS. If you want to see what a RS will do, just look at the history of CYTR, a RS all the way up to $6.60 to stay on Nasdaq then back down to .60 as the RS made it very worthwhile for shorts to jump back in again. We need a BO, we need to get TB4 into a good pharma hands where it can be properly developed, rather than to try to continue RGRX as an ongoing entity by authorizing and diluting its way back to Nasdaq. Yes, JJ says there are no plans to issues newly authorized shares. What would you expect him to say. He put the comments about Nasdaq in the proxy for a reason, didn't he? And after JJs comments about always working for shareholders interests, he does a cheap CB. Fine, but then why double down with the additional warrants? Was doubling the warrants which required assigning the remaining authorized shares leaving RGRX with few authorized shares left in the fiduciary interests of RGRX shareholders?...perhaps for insiders and outsiders JJ gave the action to. Did the doubling down on warrants give JJ a better case for the authorization of 100M more shares. Look, for those on this board who may have been recipients of that deal, congrats and I wish you the best, but JJ decision on that and to ask for 100M shares instead of lesser amount raises a lot of red flags for me.
    Obviously, a BLA approval or BO could make all my concerns be ungrounded, and I hope JJ has all his ducks in line before the BLA meeting. I can understand the need to get some additional authorized shares in view of the situation JJ finds himself at present. But in viewing the present shareholder structure of RGRX, unless one of RGRX partners should conspire with HLB for a takeover, or unless someone has been accumulating large quantities of shares (with no reporting), I don't see the need for 100M shares to be a poison pill. That 100M figure was placed for a reason, I don't think it was simply a round figure pulled out of the thin air by JJ, and I think the implications of that may not be favorable for long term shareholders who continue to see their interests diluted while insiders get the double dip of warrants as equity is moved from shareholders to those recipients. I fully know that all depends on the BLA so maybe I'm blowing in the wind here. But being in biotech makes you pay attention to those red flags and develop skepticism at times about what mgt states is their intention. GLTA
  • B
    Buy & Hold
    Question in regards to the 100m shares being asked for: why if JJ and the board knows the pooled data, bottom line results, should they ask for those additional shares? If I was JJ and confident in the data that I have seen, what is my reason to ask for more shares? Is it to pull us up from the OTC and into normal trading to reduce shorting and give a potential buyer that we “stable” and can set a consistent price/valuation? Or is it something else.

    I prefer honest insight and no conspiracy from the @sno who will just rant on and insult people.
  • d
    dontu1dr
    If you read this ARTICLE,,,
    and PAY CLOSE ATTENTION,,,
    as they EXPLAIN the REAL LIFE PROBLEMS,,,
    involved in "eye surgeries"
    which falls under "iatrogenic dry eye"...

    BIG EYE has to solve this problem,,,
    or their bottom line will be trashed,,,
    in the near future...
    That's what will HELP drive TB4 APPROVAL...

    https://link.springer.com/article/10.1007/s40123-021-00332-7

    PAY ATTENTION to the REAL WORLD STAT'S,,,
    and
    THE UNDER REPORTED PROBLEMS...

    And TB4 works,,,
    and TB4/cipro WILL HELP post surgery infections,,,
    and will meet the criteria spec'd,,,
    by the DRY EYE COUNCIL...

    THE DONKER
  • d
    dontu1dr
    Remember,,, after Gtreebnts next trading session,,,
    we'll find out the status of HLB TAKEOVER...
    Go HLB...!!!
    It would be nice to get that situation sorted out...

    THE DONKER
    Bullish
  • d
    dontu1dr
    My summary of Gtreebnt's situation:
    Late 2020 or Early Jan. 2021:
    Yang made the I'll fated deal with Bayside PE...
    Which made delay,,, after delay,,, after delay...
    Finally,,, Gtreebnt pulled the plug on that deal,,,
    and was somewhat reprimanded by S. Korean authorities,,,
    and may be penalized for a short period...
    (1 day or so banned from trading...???)

    THEN maybe:
    On September 9, SH Partners was introduced to Yang ,,,
    by Bayside and that they had negotiated,,,
    a three-party allocation of maybe 40,000,000 won,,,
    and sounds like maybe a MOU was signed,,,
    outlining the agreement...

    AND AFTER THAT,,,LOL:
    Yang signed a MOU with HLB,,,
    for 90,000,000+ won deal...

    THEN:
    October 13, 2021
    SH Partners Co., Ltd.
    filed:
    injunction prohibiting the issuance of new shares
    with 40,000,000 won damages

    ALSO:
    October 13, 2021
    Gtree Holdings Co., Ltd.
    (holder of YANGS SHARES but directed by Bayside Guy)
    wanting to force :
    Agenda No. 1: Election of an inside director
    Agenda No. 1-1: Election of an inside director Byung Heo
    Agenda 1-2: Election of an inside director

    ALL TO INHIBIT HLB,,,
    FROM TAKING CONTROL,,,
    of GTREEBNT...LOL

    I think from RGRX's PR:
    September 27, 2021
    that we should be cheering for HLB:
    QUOTE:
    """today announced that GtreeBNT, the licensee for several RegeneRx products, is being acquired by HLB Group, a Korean company that includes six biopharmaceutical and financial subsidiaries in Korea and the U.S.

    GtreeBNT announced that as part of its acquisition the company would issue approximately US$80 million of new stock and convertible bonds to HLB Group to fund ongoing programs. The new capital should speed up the clinical trials currently in progress and allow the company to focus on new drug approval. RGN-259 will remain a priority for the company."""

    BUT IT APPEARS,,,
    that YANG was willing to DANCE,,,
    with anyone who passed by...
    Which raises the question:
    What in the hell was going on over there...???

    Bayside were loan sharks...
    And Bayside introduced:
    SH Partners Co., Ltd. to YANG
    which should have,,,
    RAISED SOME EYEBROWS,,,
    AT LEAST somewhere you'd think...

    WHILE:
    HLB is successful and seems to be qualified...
    who chose them...???
    who vetted them...???
    SOMEONE OTHER THAN YANG...???

    Because the previous 2 partners,,,
    YANG chose to dance with,,,
    didn't appear to be "KEEPERS",,,
    or better yet,,,
    EVEN QUALIFIED prospects...

    Maybe ALLAN GOLDSTEIN is running RGRX,,,
    due to JJ and OTHERS,,,
    making a QUICK TRIP TO S. KOREA,,,
    to KEEP the TB4 TRIAL and IP,,,
    from being held hostage,,,
    by BAYSIDE and SH...

    Seems like we're to cheer HLB,,,
    AND the "LIFE BOAT" portion of their name,,,
    sure seems appropriate,,, huh...???

    What a situation over in S. Korea,,,
    THE sooner it is sorted out the better,,,
    and maybe someone other than YANG,,,
    IS WATCHING SHOP over there...LOL

    I personally think the TRIAL RESULTS,,,
    might well have MERIT with the FDA,,,
    if YANG hasn't lost the paperwork,,,
    or hocked it to BAYSIDE pawnshop...

    Hard to imagine tho,,,
    how things get that far off course...

    no kidding...

    any thoughts...???

    THE DONKER
  • s
    sno
    OYST woin! This is very good news for TB 4....it shows teh FDA indeed is lowering the approval bar.. Because OYST does work! You spray the irritant up ypir nose and it makes you CRY! MOre tears, mean wet eyes....so now pts walk around squirting stuff up nose, irritaing and then walk around crying :)

    GO BACK ane read carefully the PR they put out . OYSt BARELY MENTIONED corneal staining...simply because they have nothing great to show except "muddy". ALL OYST talks about and what it got approved on is.....Schirmers tests (tears) and Eye dryness . They are using those two for SIGNs and SYMPTOMS...and the FDA allowed it! And look closely. OYST stated they did just about 1,000 PATIENTS IN TWO TRIALS!. Why was RGRX forced to do THREE trials and 1,500 pts. TB 4 was under OLD rules! ACTUALLY, I just came back from the OYST 10-K...THEY FIBBED! The two late trials they use for FDA are ONSET-1 and ONSET -2. READ THIS and add it up:

    During the ONSET-2 Phase 3 clinical trial conducted in 758 subjects...
    In ONSET-1, the 182 subjects were randomly sorted.....

    WOW ADD IT UP! The FDA approved OYST with only late stage trial 940 pts....NOT over 1,00 as they state...940! SO WHY CAN'T TB4 PICK AND CHOOSE TEH 940 PTS THAT MATCH WELL?

    I have more from the 10-K NEXT! THEY got EXTREMELY MUDDY DATA OR FAIL DATA on CORNEAL STAINING!

    I
  • D
    DrPiano5
    Asked by email regarding the 100mil shares and here’s the reply I got
    “ Authorizing additional shares does not cause massive dilution. In fact, it causes no dilution. Dilution only occurs to the extent any such shares are ever issued. It is considered good corporate practice to authorize additional shares for the reasons highlighted below and we have been advised by several third parties that not doing so could jeopardize the Company’s future. ”
  • d
    dontu1dr
    DrP,,,
    A Court of LAW,,,
    looks at "legal points",,,
    and "hangs their hat" on that...
    If the current board of directors,,,
    voted down the issue of more stock,,,
    and YANG as CEO wants/needs to OVER-RIDE,,,
    that decision (and IF this is indeed the WHAT'S GOING ON...???),,,
    the PRO-HLB GROUP could have a bit of a:
    "work around"

    AND
    It will ADD TIME,,,
    and DRAIN MONEY from GTREEBNT...

    YANG'S behavior put them in one helluva position,,,
    and GTREEBNT is VULNERABLE at this point,,,
    if things take a turn to the SOUTH...

    THIS SITUATION should be watched closely...
    WHY...???

    If a BIG PHARMA with DEEP POCKETS,,,
    who may have "pushed" YANG's buttons,,,
    in the FIRST PLACE late in 2020,,,
    makes a PLAY FOR GTREEBNT,,,
    after a COUPLE of FAILED,,,
    "erratic/desperate" type deals by YANG...

    RGRX COULD HAVE a NEW PARTNER,,,
    a BIG PHARMA with legal dept who,,,
    is holding the TB4 "eye and skin" IP,,,
    including the TB4 TRIAL RESULTS...

    RGRX would/could be held hostage,,,
    by such a scenario,,,
    and would need a BIG CHECKBOOK,,,
    to attempt to recover the IP and trial results...
    and it would/could take a lot of time...

    AND the THREAT of THAT SCENARIO,,,
    would/could cause RGRX to vote,,,
    100,000,000 SHARE's in reserve,,,
    I don't care what excuses,,,
    they would convey to stockholders...

    THIS SITUATION isn't over,,,
    'til it's over I'm thinking...
    Well worth watching,,,
    and "mentally preparing" for a possible delay...
    or a typical RGRX SNAFU...

    THE DONKER
  • d
    dontu1dr
    If the buyout is before TB4 approval,,,
    and is a stock-swap,,,
    I look for it to be valued $4 or a little less...
    AND maybe CVR's for MILESTONES on TB4...
    With the right company,,,
    you would have some gain in the STOCKS,,,
    that you received for your RGRX SHARES...

    With the age of the management and board,,,
    they would want to de-risk another RGRX DEBACLE,,,
    of which they have experienced many over the years...

    Also,,, they stock swap would help tax wise to management,,,
    and insiders who have very large positions...

    THE exceptionally low price of RGRX for years,,,
    has TELEGRAPHED this scenario,,,
    whether some like it or not...
    It's been HISTORICAL VALIDATION of a FUTURE EVENT...

    And the low price of RGRX STOCK,,,
    has given the INSIDERS an extremely low basis,,,
    THUS they profit large with small investments...

    Plus,,, WHOMEVER get's RGRX,,,
    it will be a real bargain in the long run,,,
    and they will sell/trade additional IP for,,,
    cash and/or more pharma...

    Maybe the CVR'S would/could be linked,,,
    to the selling/swapping of the IP other than TB4 EYE...

    Any who,,,
    TIME will tell...
    and TIME is "murmur-ing" even now...

    THE DONKER
    Bullish
  • M
    Mr. Wolf
    Right on cue....@david, the message board White Knight coming to save us from the evil insiders the minute a sensible comment appears. By now it should be clear that insiders can talk up the stock all they want but without news no new retailers will appear so the argument that insiders are having any affect seems far fatched. I'm no expert but something is going to happen here, otherwise why all the building dramA.
  • D
    DrW
    OK, I must have been asleep at the switch. Where did this request for authorization of 100M more shares come from? Gtree's max # of shares are fixed and JJ has a veto on JV, so why the request if factual. JJ, you have a number of shareholder with very substantial positions who have been with you since ALBM, and we will not be happy with a dilution that large, particularly while insiders keep getting shares and options at very favorable price as per recent offering. I have seen too often, when a biotech co gets close to BO, mgt & insiders seek increase in authorized shares, then grant themselves more shares/options at favorable terms so they get a bigger piece of the pie at the expense of long term retail shareholders. Say it ain't so, or give me a rational and legal reason why necessary while meeting Mgt's fiduciary responsibility to shareholders, or will we be left outside the "loop" again?
  • d
    dontu1dr
    Another great article on "Iatrogenic Dry Eye",,,
    that will show some other involvements (2018):
    https://www.reviewofcontactlenses.com/article/look-out-for-iatrogenic-dry-eye

    SO,,, BIG EYE will want TB4 EYE,,,
    to support their other DIVISIONS...
    OR

    BIG EYE/PHARMA:
    Surgery (pre and post op)
    Lasik (pre and post op)
    Contact Lens
    Dry Eye
    ect

    Will be impacted by not having a solution...
    no kidding...

    THE DONKER
    Look Out for Iatrogenic Dry Eye
    www.reviewofcontactlenses.com
    Bullish
  • d
    dontu1dr
    https://link.springer.com/article/10.1007/s40123-021-00332-7
    Helluva good article,,,
    just in case you missed it...

    Really gives an idea what
    "IATROGENIC DRY EYE" causes,,,
    and real life consequences if this problem,,,
    is not solved...

    Do search on:
    "quality of life" or QOL

    THAT'S the bench mark we should us for "seniors",,,
    not some obscure stats,,,
    no kidding...

    Good for these authors,,,
    to "clarify" and give,,,
    "real world" consequences...

    Go TB4 EYE,,,
    as it's a:
    "iatrogenic dry eye buster"...lol

    THE DONKER
    The incidence and prevalence of dry eye disease (DED) after cataract surgery is greatly underestimated. The severity of dry eye symptoms has been reported to peak 7 days after cataract surgery and may persist for months, significantly affecting patie
    The incidence and prevalence of dry eye disease (DED) after cataract surgery is greatly underestimated. The severity of dry eye symptoms has been reported to peak 7 days after cataract surgery and may persist for months, significantly affecting patie
    link.springer.com
  • d
    david
    Attention delusional junior investors:

    Donker is an insider paid to gin up support for this mess of an outfit. Why do you think he writes 10 long messages a day all implying salvation is on the horizon.

    Issuing 100 mil shares of a 20 mil cap stock is a 100% indication that a reverse split is on the horizon.

    The FDA will never support an organization like this with a US authorization...even for a BLA application.

    They will try to raise money again with reverse split pricing before hearing of rejection from the FDA.

    But good luck, you will need it. It's a tough business
  • d
    dontu1dr
    What folks in RGRX SHOULD RECOGNIZE,,,
    that in S. Korean TB4 RIGHTS,,,
    and TERRITORY are UNDER a CHANGE OF CONTROL,,,
    and it looks like that will happen,,,
    for a value of about $76 MILLION USD...

    AND this all happened about the time,,,
    the TB4 EYE TRIAL was being,,,
    wrapped up...
    AND the FDA is SOFTENING THEIR STANCE,,,
    on DRY EYE TRIALS...

    Both of the ORIGINAL CO-CEO'S:
    PARK II and W. YANG,,,
    were dethroned and seemingly,,,
    lost control of their 5% stock holdings...
    They both were totally out maneuvered...LOL
    A true FINANCIAL Coup d'état...

    AND:
    Keep in mind that Sigma Tau/Essetifin,,,
    were "more than likely" involved in,,,
    setting up Gtreebnt as the "first strategic"
    initiative was giving GTREEBNT the TB4 IP,,,
    on the CHEAP as well as,,,
    20 MILLION SHARES of RGRX...

    THE "second strategic' initiative involving,,,
    GTREEBNT was right after GTREEBNT,,,
    met with NOVARTIS,,,
    "one on one" in the SWISS EMBASSY,,,
    to discuss "collaborations"
    AND THEN:
    GTREEBNT MAGICALLY came up with,,,
    a GLIOBLASTOMA DRUG from OMRF,,,

    AND:
    Novartis QUITE LITERALLY,,,
    put OMRF on the BIOTECH MAP,,,
    with SELEXYS... read a bit on it...

    WITH that said,,,
    YOU can SEE that there are at LEAST,,,
    2 ENTITIES at work behind the SCENES,,,
    in GTREEBNT...

    IS there DISCORD between them...???
    IS there a WINNER take all type of event,,,
    in the making...???
    AND:
    If there is,,,
    HLB might not have RGRX'S BEST INTERESTS,,,
    at "heart",,, if you know what I MEAN...LOL

    If there's other OUTSIDE INTERESTS,,,
    that are causing the ALL HUBBUB,,,
    in S. Korea,,,
    and the original two entities,,,
    are still "aligned",,,
    that's a whole different scenario...

    But the $64,000 question:
    for RGRX'ers

    "Where does HLB fit into all this?"
    VS
    ASSUMING they are pro RGRX interests...

    This is a DICEY SITUATION at the very LEAST,,,
    that is PLAYING OUT in S. KOREA with RGRX'S,,,
    partner GTREEBNT who at this point controls,,,
    The IP and TRIAL results on TB4 EYE...

    REGENERX really has a DUTY,,,
    to CLARIFY this SITUATION,,,
    to their STOCKHOLDERS,,, ASAP,,,
    as it is RELEVANT...
    AND
    RGRX would be aware of what is going on,,,
    in S. Korea...

    MAYBE throw us a bone ALLAN...???
    doesn't have to be the whole story...
    nothing that would compromise negotiations...
    just a bit of guidance...
    As our interests seemingly aligned with yours ALLAN...

    AS what's going on in S. Korean's Gtreebnt,,,
    AIN'T NORMAL...

    THE DONK
Advertisement
Advertisement